102.17
0.84%
-0.87
Pre-market:
100.55
-1.62
-1.59%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cardinal Health, Inc. stock is currently priced at $102.17, with a 24-hour trading volume of 2.66M.
It has seen a -0.84% decreased in the last 24 hours and a -8.83% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $102.9 pivot point. If it approaches the $102.0 support level, significant changes may occur.
Previous Close:
$103.04
Open:
$102.25
24h Volume:
2.66M
Market Cap:
$24.85B
Revenue:
$216.15B
Net Income/Loss:
$639.00M
P/E Ratio:
167.49
EPS:
0.61
Net Cash Flow:
$3.42B
1W Performance:
-1.32%
1M Performance:
-8.83%
6M Performance:
+9.18%
1Y Performance:
+24.22%
Cardinal Health, Inc. Stock (CAH) Company Profile
Name
Cardinal Health, Inc.
Sector
Industry
Phone
614-757-5000
Address
7000 Cardinal Place, Dublin, OH
Cardinal Health, Inc. Stock (CAH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-09-24 | Upgrade | Argus | Hold → Buy |
Jan-03-24 | Initiated | Barclays | Overweight |
Dec-14-23 | Initiated | Wells Fargo | Underweight |
Jul-10-23 | Downgrade | Evercore ISI | Outperform → In-line |
Mar-31-23 | Initiated | Citigroup | Neutral |
Feb-03-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
Nov-04-22 | Upgrade | BofA Securities | Underperform → Neutral |
Aug-22-22 | Resumed | Morgan Stanley | Overweight |
May-26-22 | Downgrade | Barclays | Overweight → Equal Weight |
May-18-22 | Upgrade | Evercore ISI | In-line → Outperform |
Apr-12-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Apr-01-22 | Resumed | Credit Suisse | Neutral |
Aug-06-21 | Downgrade | Deutsche Bank | Buy → Hold |
Aug-05-21 | Downgrade | BofA Securities | Buy → Underperform |
May-10-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
Jan-08-21 | Upgrade | Wolfe Research | Underperform → Peer Perform |
Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
Sep-25-20 | Upgrade | Deutsche Bank | Hold → Buy |
Jul-20-20 | Upgrade | Guggenheim | Neutral → Buy |
May-15-20 | Upgrade | UBS | Neutral → Buy |
Apr-23-20 | Resumed | Credit Suisse | Neutral |
Mar-20-20 | Upgrade | BofA/Merrill | Underperform → Buy |
Feb-12-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
Dec-16-19 | Downgrade | Guggenheim | Buy → Neutral |
Sep-12-19 | Initiated | Deutsche Bank | Hold |
Aug-27-19 | Downgrade | Argus | Buy → Hold |
Aug-20-19 | Upgrade | Guggenheim | Neutral → Buy |
Apr-18-19 | Initiated | Guggenheim | Neutral |
Jan-17-19 | Initiated | UBS | Neutral |
Nov-16-18 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
Apr-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
Apr-02-18 | Upgrade | Argus | Hold → Buy |
Mar-08-18 | Initiated | Barclays | Equal Weight |
Feb-27-18 | Resumed | BofA/Merrill | Underperform |
Jan-05-18 | Initiated | Evercore ISI | In-line |
View All
Cardinal Health, Inc. Stock (CAH) Latest News
What You Should Know About Block (SQ) Ahead of Q1 Earnings
Zacks Investment Research
What You Should Do With MercadoLibre (MELI) Ahead of Q1 Earnings
Zacks Investment Research
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
Zacks Investment Research
Merit Medical (MMSI) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research
Earnings Preview: McKesson (MCK) Q4 Earnings Expected to Decline
Zacks Investment Research
AMETEK (AME) to Report Q1 Earnings: What's in the Offing?
Zacks Investment Research
Cardinal Health, Inc. Stock (CAH) Financials Data
Cardinal Health, Inc. (CAH) Revenue 2024
CAH reported a revenue (TTM) of $216.15 billion for the quarter ending December 31, 2023, a +11.99% rise year-over-year.
Cardinal Health, Inc. (CAH) Net Income 2024
CAH net income (TTM) was $639.00 million for the quarter ending December 31, 2023, a +150.20% increase year-over-year.
Cardinal Health, Inc. (CAH) Cash Flow 2024
CAH recorded a free cash flow (TTM) of $3.42 billion for the quarter ending December 31, 2023, a +22.53% increase year-over-year.
Cardinal Health, Inc. (CAH) Earnings per Share 2024
CAH earnings per share (TTM) was $2.54 for the quarter ending December 31, 2023, a +154.62% growth year-over-year.
Cardinal Health, Inc. Stock (CAH) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
WEITZMAN DEBORAH | CEO, Pharmaceutical Segment |
Nov 27 '23 |
Option Exercise |
74.10 |
27,642 |
2,048,356 |
71,844 |
WEITZMAN DEBORAH | CEO, Pharmaceutical Segment |
Nov 27 '23 |
Sale |
106.31 |
36,642 |
3,895,411 |
35,202 |
WEITZMAN DEBORAH | CEO, Pharmaceutical Segment |
Aug 28 '23 |
Option Exercise |
71.43 |
6,712 |
479,438 |
50,914 |
WEITZMAN DEBORAH | CEO, Pharmaceutical Segment |
Aug 28 '23 |
Sale |
89.81 |
6,712 |
602,805 |
44,202 |
Scherer Mary C. | Chief Accounting Officer |
Aug 18 '23 |
Option Exercise |
75.36 |
11,460 |
863,646 |
31,344 |
Scherer Mary C. | Chief Accounting Officer |
Aug 18 '23 |
Sale |
86.27 |
20,695 |
1,785,358 |
10,649 |
Snow Ola M | Chief Human Resources Officer |
Aug 17 '23 |
Option Exercise |
71.43 |
3,907 |
279,077 |
52,086 |
Mason Stephen M | CEO, Medical Segment |
Aug 17 '23 |
Sale |
87.32 |
37,500 |
3,274,642 |
37,355 |
Snow Ola M | Chief Human Resources Officer |
Aug 17 '23 |
Sale |
87.41 |
26,324 |
2,301,053 |
25,762 |
Mayer Jessica L | Chief Legal/Compliance Officer |
Aug 17 '23 |
Sale |
87.68 |
10,668 |
935,370 |
84,865 |
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company operates through two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. It also provides services to support the development, marketing, and distribution of specialty pharmaceutical products, as well as pharmacy management, and medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products. It also distributes a range of national brand products; and medical products to patients' homes, as well as provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Cap:
|
Volume (24h):